Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrante, A. W.
Right arrow Articles by Leibel, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrante, A. W.
Right arrow Articles by Leibel, R. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2268-2278, 2001
© 2001 by the American Diabetes Association, Inc.

Effects of Leptin Deficiency and Short-Term Repletion on Hepatic Gene Expression in Genetically Obese Mice

Anthony W. Ferrante, Jr.,1, Marie Thearle1, Ted Liao2, and Rudolph L. Leibel1,2

1 Medicine and
2 Pediatrics, Naomi Berrie Diabetes Center, Columbia University College of Physicians & Surgeons, New York, New York

By supplying most organs of the body with metabolic substrates, the liver plays a central role in maintaining energy balance. Hepatic metabolism of glucose, fatty acids, and lipoproteins is disrupted in the leptin-deficient obese (Lepob/Lepob) mouse, leading to hyperglycemia, steatosis, and hypercholesterolemia. Microarray expression profiles were used to identify transcriptional perturbations that underlie the altered hepatic physiology of Lepob/Lepob mice. A wide variety of genes involved in fatty acid metabolism are altered in expression, which suggests that both fatty acid synthesis and oxidation programs are activated in obese mice. The expression of a small subset of genes is upregulated by leptin deficiency, not modulated by caloric restriction, and markedly suppressed by short-term leptin treatment. Among these leptin-regulated genes, apolipoprotein A-IV is a strong candidate for mediating the atherogenic-resistant phenotype of Lepob/Lepob mice.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. L. Gruen, M. R. Plummer, W. Zhang, K. A. Posey, M. Linton, S. Fazio, and A. H. Hasty
Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I
J. Lipid Res., September 1, 2005; 46(9): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Barazzoni, M. Zanetti, A. Bosutti, G. Biolo, L. Vitali-Serdoz, M. Stebel, and G. Guarnieri
Moderate Caloric Restriction, But Not Physiological Hyperleptinemia Per Se, Enhances Mitochondrial Oxidative Capacity in Rat Liver and Skeletal Muscle--Tissue-Specific Impact on Tissue Triglyceride Content and AKT Activation
Endocrinology, April 1, 2005; 146(4): 2098 - 2106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ohsugi, C. Cras-Meneur, Y. Zhou, E. Bernal-Mizrachi, J. D. Johnson, D. S. Luciani, K. S. Polonsky, and M. A. Permutt
Reduced Expression of the Insulin Receptor in Mouse Insulinoma (MIN6) Cells Reveals Multiple Roles of Insulin Signaling in Gene Expression, Proliferation, Insulin Content, and Secretion
J. Biol. Chem., February 11, 2005; 280(6): 4992 - 5003.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Chiellini, F. Santini, A. Marsili, P. Vitti, A. Pinchera, and M. Maffei
Authors' Response: Haptoglobin and Body Mass Index
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 594 - 595.
[Full Text] [PDF]


Home page
J. Nutr.Home page
P. Cohen and J. M. Friedman
Leptin and the Control of Metabolism: Role for Stearoyl-CoA Desaturase-1 (SCD-1)
J. Nutr., September 1, 2004; 134(9): 2455S - 2463S.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Ohsugi, C. Cras-Meneur, Y. Zhou, W. Warren, E. Bernal-Mizrachi, and M. A. Permutt
Glucose and Insulin Treatment of Insulinoma Cells Results in Transcriptional Regulation of a Common Set of Genes
Diabetes, June 1, 2004; 53(6): 1496 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Ahluwalia, K. H. Clodfelter, and D. J. Waxman
Sexual Dimorphism of Rat Liver Gene Expression: Regulatory Role of Growth Hormone Revealed by Deoxyribonucleic Acid Microarray Analysis
Mol. Endocrinol., March 1, 2004; 18(3): 747 - 760.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. Simha, L. S. Szczepaniak, A. J. Wagner, A. M. DePaoli, and A. Garg
Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy
Diabetes Care, January 1, 2003; 26(1): 30 - 35.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Cohen, M. Miyazaki, N. D. Socci, A. Hagge-Greenberg, W. Liedtke, A. A. Soukas, R. Sharma, L. C. Hudgins, J. M. Ntambi, and J. M. Friedman
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Science, July 12, 2002; 297(5579): 240 - 243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.